Vanda Pharmaceuticals

Nasdaq VNDA · Washington, DC

Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Neurology · Ophthalmology · Psychiatry · Respiratory

Vanda Pharmaceuticals is a clinical trial sponsor based in Washington, DC, listed as Nasdaq VNDA. It has 16 active clinical trials with 4,908 planned participants, across 12 therapeutic areas. Since 2021 it has completed 33 trials and stopped 5 early. Its FDA record on file shows compliance actions.

Trial track record · since 2021

16Active trials4,908 planned participants
33Completed24 with results posted
5Stopped early13% of finished trials

FDA record

0InspectionsNone posted since 2025
0Warning lettersNone on file
0RecallsNone on file

Recent FDA actions

Financials · Nasdaq VNDA

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Fundraising

No SEC Form D filings under this name. A private round is only public when the company files one.

Pipeline · 16 active trials

StageTrialStatus

On the market · 6 products

  • HETLIOZ LQ tasimelteon · NDA 214517 · prescription
  • NEREUS tradipitant · NDA 220152 · prescription
  • PONVORY ponesimod · NDA 213498 · prescription
  • BYSANTI milsaperidone · NDA 220358 · prescription
  • FANAPT iloperidone · NDA 022192 · prescription
  • HETLIOZ tasimelteon · NDA 205677 · prescription

Questions about Vanda Pharmaceuticals

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-19.

The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.

Products come from FDA's drug application database and, for vaccines, cell and gene therapies and blood products, FDA's Purple Book of licensed biologics; checked 2026-09-23.

Approve Suite is not affiliated with Vanda Pharmaceuticals.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.